Are Options Traders Bullish on ALNY?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ALNY

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is leading the translation of RNAi as a new class of innovative medicines. Alnylams pipeline of investigational RNAi therapeutics is focused in 3 Strategic Therapeutic Areas (STArs): Genetic Medicines, with a broad pipeline of RNAi therapeutics for the treatment of rare diseases; Cardio-Metabolic Disease, with a pipeline of RNAi therapeutics toward genetically validated, liver-expressed disease targets for unmet needs in cardiovascular and metabolic diseases; and Hepatic Infectious Disease, with a pipeline of RNAi therapeutics that address the major global health challenges of hepatic infectious diseases. In early 2015, Alnylam launched its Alnylam 2020 guidance for the advancement and commercialization of RNAi therapeutics as a whole new class of innovative medicines. Specifically, by the end of 2020, Alnylam expects to achieve a company profile with 3 marketed products, 10 RNAi therapeutic clinical programs including 4 in late stages of development across its 3 STArs. The companys demonstrated commitment to RNAi therapeutics has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, Biogen, Roche, Takeda, Kyowa Hakko Kirin, Cubist, GlaxoSmithKline, Ascletis, Monsanto, The Medicines Company, and Genzyme, a Sanofi company. In addition, Alnylam holds an equity position in Regulus Therapeutics Inc., a company focused on discovery, development, and commercialization of microRNA therapeutics. Founded in 2002, Alnylam maintains headquarters in Cambridge, Massachusetts. www.alnylam.com.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALNY is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BBH VanEck Vectors Biotech ETF 411.2 M 4.112E+08 25 25 1.85% 0.0185 7.6 M 7618910
BIB ProShares Ultra Nasdaq Biotechnology 299.5 M 2.99484E+08 202 202 0.44% 0.00444637 2.8 M 2791640
EQAL Invesco Russell 1000 Equal Weight ETF 453.0 M 4.53E+08 971 971 0.09% 0.0009 409 K 408525
EQWM Invesco Russell Midcap Equal Weight ETF 23.7 M 2.37E+07 777 777 0.13% 0.00134 32 K 31751
EUSA iShares MSCI USA Equal Weighted ETF 201.8 M 2.01844E+08 623 623 0.11% 0.0011 226 K 226430
FBT First Trust Amex Biotech Index Fund 2.7 B 2.69915E+09 30 30 3.37% 0.0337 91.0 M 9.096136E+07
FHLC Fidelity MSCI Health Care Index ETF 1.6 B 1.6E+09 347 347 0.15% 0.00153229 2.4 M 2424760
FTLS First Trust Long/Short Equity 156.3 M 1.56327E+08 243 243 -0.27% -0.0027 -428 K -427693
IBB iShares Nasdaq Biotechnology Index Fund 8.1 B 8.1173E+09 191 191 1.03% 0.0103 84.3 M 8.4314E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.6 B 1.55899E+10 3,421 3421 0.02% 0.0002 3.5 M 3539050
IWB iShares Russell 1000 ETF 17.1 B 1.70905E+10 985 985 0.03% 0.0003 4.3 M 4277450
IWD iShares Russell 1000 Value ETF 38.0 B 3.80136E+10 727 727 0.01% 0.0001 2.2 M 2170290
IWF iShares Russell 1000 Growth ETF 40.6 B 4.06362E+10 542 542 0.05% 0.0005 18.4 M 1.84472E+07
IWP iShares Russell Midcap Growth ETF 8.6 B 8.59967E+09 416 416 0.2% 0.002 17.5 M 1.74847E+07
IWR iShares Russell Mid-Cap ETF 17.4 B 1.73546E+10 789 789 0.09% 0.0009 16.2 M 1.61673E+07
IWS iShares Russell Mid-cap Value ETF 11.0 B 1.10434E+10 592 592 0.02% 0.0002 1.9 M 1943720
IWV iShares Russell 3000 ETF 8.4 B 8.44137E+09 3,007 3007 0.02% 0.0002 1.9 M 1870490
IYH iShares U.S. Healthcare ETF 2.5 B 2.50122E+09 131 131 0.17% 0.0017 4.3 M 4270860
IYY iShares Dow Jones U.S. ETF 1.2 B 1.18097E+09 1,233 1233 0.02% 0.0002 292 K 291689
JKH iShares Morningstar Mid-Cap Growth ETF 316.1 M 3.16098E+08 200 200 0.36% 0.0036 1.1 M 1135740
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 1,029 1029 0.05% 0.000507461 940 K 940449
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 2.0 B 1.9592E+09 1,447 1447 0.03% 0.0003 585 K 585426
QUS SPDR MSCI USA StrategicFactors ETF 112.1 M 1.1209E+08 622 622 0.0% 1.242E-05 1 K 1387
RXL ProShares Ultra Health Care 145.3 M 1.4531E+08 141 141 0.07% 0.00071143 219 K 219041
SIZE iShares Edge MSCI USA Size Factor ETF 207.5 M 2.07459E+08 623 623 0.01% 0.0001 23 K 23045
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.40126E+09 1,904 1904 0.02% 0.000174 240 K 239672
UBIO Proshares UltraPro Nasdaq Biotechnology 30.8 M 3.08062E+07 196 196 0.2% 0.00204023 210 K 209896
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.4 B 4.43077E+09 126 126 1.11% 0.011114 48.1 M 4.806044E+07

Wait, Before You Leave...